Literature DB >> 11044077

Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.

S El Mehdaoui1, A Touzé, S Laurent, P Y Sizaret, D Rasschaert, P Coursaget.   

Abstract

The aim of this study was to produce gene transfer vectors consisting of plasmid DNA packaged into virus-like particles (VLPs) with different cell tropisms. For this purpose, we have fused the N-terminally truncated VP60 capsid protein of the rabbit hemorrhagic disease virus (RHDV) with sequences which are expected to be sufficient to confer DNA packaging and gene transfer properties to the chimeric VLPs. Each of the two putative DNA-binding sequences of major L1 and minor L2 capsid proteins of human papillomavirus type 16 (HPV-16) were fused at the N terminus of the truncated VP60 protein. The two recombinant chimeric proteins expressed in insect cells self-assembled into VLPs similar in size and appearance to authentic RHDV virions. The chimeric proteins had acquired the ability to bind DNA. The two chimeric VLPs were therefore able to package plasmid DNA. However, only the chimeric VLPs containing the DNA packaging signal of the L1 protein were able efficiently to transfer genes into Cos-7 cells at a rate similar to that observed with papillomavirus L1 VLPs. It was possible to transfect only a very limited number of RK13 rabbit cells with the chimeric RHDV capsids containing the L2-binding sequence. The chimeric RHDV capsids containing the L1-binding sequence transfer genes into rabbit and hare cells at a higher rate than do HPV-16 L1 VLPs. However, no gene transfer was observed in human cell lines. The findings of this study demonstrate that the insertion of a DNA packaging sequence into a VLP which is not able to encapsidate DNA transforms this capsid into an artificial virus that could be used as a gene transfer vector. This possibility opens the way to designing new vectors with different cell tropisms by inserting such DNA packaging sequences into the major capsid proteins of other viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044077      PMCID: PMC110907          DOI: 10.1128/jvi.74.22.10332-10340.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Truncation of the nuclear localization signal of polyomavirus VP1 results in a loss of DNA packaging when expressed in the baculovirus system.

Authors:  E T Gillock; K An; R A Consigli
Journal:  Virus Res       Date:  1998-11       Impact factor: 3.303

2.  Papillomavirus capsid binding and uptake by cells from different tissues and species.

Authors:  M Müller; L Gissmann; R J Cristiano; X Y Sun; I H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection.

Authors:  S Laurent; J F Vautherot; M F Madelaine; G Le Gall; D Rasschaert
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Authors:  J T Douglas; C R Miller; M Kim; I Dmitriev; G Mikheeva; V Krasnykh; D T Curiel
Journal:  Nat Biotechnol       Date:  1999-05       Impact factor: 54.908

5.  The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.

Authors:  J G Joyce; J S Tung; C T Przysiecki; J C Cook; E D Lehman; J A Sands; K U Jansen; P M Keller
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

6.  Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.

Authors:  R J Pickles; D McCarty; H Matsui; P J Hart; S H Randell; R C Boucher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.

Authors:  T Sasagawa; P Pushko; G Steers; S E Gschmeissner; M A Hajibagheri; J Finch; L Crawford; M Tommasino
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

8.  In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.

Authors:  K Kawana; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells.

Authors:  C Volpers; F Unckell; P Schirmacher; R E Streeck; M Sapp
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  14 in total

1.  Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.

Authors:  Latifa Bousarghin; Alba-Lucia Combita-Rojas; Antoine Touzé; Slimane El Mehdaoui; Pierre-Yves Sizaret; Maria-Mercedes Bravo; Pierre Coursaget
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  HPV pseudovirions as DNA delivery vehicles.

Authors:  Barbara Ma; Richard B S Roden; Chien-Fu Hung; T C Wu
Journal:  Ther Deliv       Date:  2011-04

3.  Recovery of infectious rabbit hemorrhagic disease virus from rabbits after direct inoculation with in vitro-transcribed RNA.

Authors:  Guangqing Liu; Yuying Zhang; Zheng Ni; Tao Yun; Zutian Sheng; Huali Liang; Jionggang Hua; Shuangmao Li; Qingyun Du; Jianping Chen
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Papillomavirus assembly: An overview and perspectives.

Authors:  Carla Cerqueira; John T Schiller
Journal:  Virus Res       Date:  2016-11-10       Impact factor: 3.303

5.  Interactions between papillomavirus L1 and L2 capsid proteins.

Authors:  Renée L Finnen; Kimberly D Erickson; Xiaojiang S Chen; Robert L Garcea
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells.

Authors:  Latifa Bousarghin; Antoine Touzé; Pierre-Yves Sizaret; Pierre Coursaget
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Efficient delivery of DNA vaccines using human papillomavirus pseudovirions.

Authors:  S Peng; A Monie; T H Kang; C-F Hung; R Roden; T-C Wu
Journal:  Gene Ther       Date:  2010-07-29       Impact factor: 5.250

8.  Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Authors:  Alba-Lucia Combita; Antoine Touzé; Latifa Bousarghin; Neil D Christensen; Pierre Coursaget
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 9.  Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review.

Authors:  Joana Abrantes; Wessel van der Loo; Jacques Le Pendu; Pedro J Esteves
Journal:  Vet Res       Date:  2012-02-10       Impact factor: 3.683

10.  The epidemiology of conjunctival squamous cell carcinoma in Uganda.

Authors:  R Newton; J Ziegler; C Ateenyi-Agaba; L Bousarghin; D Casabonne; V Beral; E Mbidde; L Carpenter; G Reeves; D M Parkin; H Wabinga; S Mbulaiteye; H Jaffe; D Bourboulia; C Boshoff; A Touzé; P Coursaget
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.